companydata.dkcompanydata.dk

Roche Pharmaceuticals A/S: Financial statements 2019

CVR: 25230515

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

Roche Pharmaceuticals A/S (CVR 25230515) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 718,237,000 and a net result of DKK 21,755,000 compared with DKK 30,177,000 the year before. That is a decrease of 11.1% compared with the year before. The profit margin was 3%. Equity in the 2019 report amounted to DKK 159,934,000. The solvency ratio was 45.5%. The company had 121 employees in the financial year.

Revenue
DKK 718,237,000
Gross Profit
DKK 126,123,000
Profit/Loss
DKK 21,755,000
Equity
DKK 159,934,000
Total Assets
DKK 351,751,000
Employees
121

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019718.2 mio.126.1 mio.21.8 mio.159.9 mio.121
2018808.2 mio.152.9 mio.30.2 mio.138.2 mio.120
2017897.9 mio.165.9 mio.33.1 mio.158 mio.122
2016869.9 mio.146.5 mio.25.5 mio.124.9 mio.125
2015893.7 mio.161.1 mio.29.2 mio.129.4 mio.111

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Ehab Abdelmoneim Youssef Hassan joins the board of Roche Pharmaceuticals A/SOct 31, 2019

As of October 31, 2019, Ehab Abdelmoneim Youssef Hassan has joined the board of directors of Roche Pharmaceuticals A/S.

Luc Jozef Leon Dirckx leaves the board of Roche Pharmaceuticals A/SOct 31, 2019

As of October 31, 2019, Luc Jozef Leon Dirckx has left the board of directors of Roche Pharmaceuticals A/S.

Roche Pharmaceuticals A/S: The 2018 annual report is outMay 21, 2019

Roche Pharmaceuticals A/S has published its annual report for 2018. Revenue came to DKK 808,154,000, and the net result was DKK 30,177,000.

Beat Christoph Krähenmann joins the board of Roche Pharmaceuticals A/SApr 29, 2019

As of April 29, 2019, Beat Christoph Krähenmann has joined the board of directors of Roche Pharmaceuticals A/S.

Michael Egede Budtz leaves the board of Roche Pharmaceuticals A/SApr 29, 2019

As of April 29, 2019, Michael Egede Budtz has left the board of directors of Roche Pharmaceuticals A/S.

Beat Christoph Krähenmann leaves the board of Roche Pharmaceuticals A/SApr 28, 2019

As of April 28, 2019, Beat Christoph Krähenmann has left the board of directors of Roche Pharmaceuticals A/S.

About Roche Pharmaceuticals A/S

Roche Pharmaceuticals A/S is a Danish company of the type Aktieselskab based in København V, founded in 1970. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ROCHE A/S. MEDICINALVARER & KEMIKALIER. The management consists of Carole Hassoun. The board consists of Isabel Marianne Joerin (chair), Carole Hassoun and Ehab Abdelmoneim Youssef Hassan. The company is owned by Roche Holding AG. The company has 96 employees (2026). In 2025, the company reported revenue of DKK 928,824,000 and a net result of DKK 31,319,000 compared with DKK 24,277,000 the year before. Equity in the 2025 report amounted to DKK 195,179,000.

Source: annual report 2025, Danish Business Authority